Psychiatry

A recent study suggests that an 8-week online mindfulness program may help alleviate dyspnea in patients with interstitial lung disease, a condition often resistant to conventional treatments.

A randomized, placebo-controlled trial found that executive working memory training leads to significant behavioral improvements in adolescents with attention-deficit/hyperactivity disorder.

Two randomized, double-blind studies demonstrated that a new antipsychotic treatment for adult patients with schizophrenia may lead to a meaningful reduction in symptoms.

Researchers sought to evaluate the risk of patients newly diagnosed with alopecia areata developing psychiatric or autoimmune disease after diagnosis.

A team of researchers examined the possibility of harmful risks associated with the discontinuation of long-term benzodiazepine use in patients.

Researchers examined how the availability of mental health services and patient specific characteristics impacted levels of anxiety and depression in residents of long-term care settings following COVID-19...

Researchers examined the characteristics and trends related to the increased mortality rates associated with overdose in pregnant and postpartum women.

Following two randomized studies, the FDA has approved zuranolone for the treatment of postpartum depression in adults—the first if its kind.

The USPSTF has updated its recommendations on screening adults for major depressive disorder (MDD) and suicide risk.